National Health Investors, Inc. (NHI) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 18 analysts17.8% Below Target
NHI trades 17.8% below Wall Street's consensus target of $83.40.
Current Price$70.82
Average Target$83.40
Target
Current
Low$80.00
Median$85.00
High$86.00
Analyst Target Range
Forward P/E19.9x
(Fair)
PEG Ratio—
Implied Growth+16.7%
(Moderate)
Analyst Spread7.2%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes NHI achieves its forward estimates and maintains a stable P/E multiple of 19.9x. This scenario reflects the blended consensus of 18 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
NHI Price Target Analysis
Updated June 21, 2026As of June 21, 2026, National Health Investors, Inc. (NHI) has a Wall Street consensus price target of $83.40, based on estimates from 18 covering analysts. With the stock currently trading at $70.82, this represents a potential upside of +17.8%. The company has a market capitalization of $3.43B.
Analyst price targets range from a low of $80.00 to a high of $86.00, representing a 7% spread in expectations. The median target of $85.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 6 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, NHI trades at a trailing P/E of 23.5x and forward P/E of 19.9x. Analysts expect EPS to grow +16.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $82.75, with bear and bull scenarios of $52.13 and $109.03 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Real Estate stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+20.7%
Industry Consensus
Avg Forward P/E
111.8x
(High Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 OHIOmega Healthcare Investors, Inc. | $13.3B | $44.53 | $50.43 | +13.2% | Hold | 22.4x | 28 |
 SBRASabra Health Care REIT, Inc. | $4.6B | $18.12 | $21.00 | +15.9% | Hold | 26.9x | 29 |
 LTCLTC Properties, Inc. | $1.9B | $36.37 | $36.00 | -1.0% | Hold | 19.4x | 22 |
 CTRECareTrust REIT, Inc. | $8.8B | $37.06 | $44.25 | +19.4% | Buy | 24.8x | 19 |
 GMREGlobal Medical REIT Inc. | $94M | $35.74 | $40.00 | +11.9% | Buy | 595.7x | 22 |
 VTRVentas, Inc. | $38.8B | $81.61 | $95.86 | +17.5% | Buy | 130.8x | 32 |
 WELLWelltower Inc. | $144.8B | $206.65 | $237.80 | +15.1% | Buy | 71.3x | 34 |
 HRHealthcare Realty Trust Incorporated | $6.9B | $19.79 | $21.83 | +10.3% | Hold | — | 30 |
 DOCHealthpeak Properties, Inc. | $13.6B | $19.56 | $19.71 | +0.8% | Buy | 65.5x | 41 |
 MPWMedical Properties Trust, Inc. | $3.4B | $5.65 | $11.54 | +104.2% | Hold | 49.4x | 28 |
NHI — Frequently Asked Questions
Quick answers to the most common questions about buying NHI stock.
What is the NHI stock price target for 2026?
National Health Investors, Inc. (NHI) has a consensus 12-month price target of $83.4, implying 17.8% upside from $70.82. The 18 analysts covering NHI see moderate appreciation potential.
Is NHI a buy, sell, or hold?
NHI has a consensus rating of "Hold" based on 18 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $83.4 implies 17.8% upside from current levels.
Is NHI stock overvalued or undervalued?
With a forward P/E of 19.8994x, NHI trades at a relatively low valuation. The consensus target of $83.4 implies 17.8% appreciation, suggesting meaningful undervaluation.
How high can NHI stock go?
The most bullish Wall Street analyst has a price target of $86 for NHI, while the most conservative target is $80. The consensus of $83.4 represents the median expectation. Our quantitative valuation model projects a bull case target of $109 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover NHI stock?
NHI is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NHI stock forecast?
The 12-month NHI stock forecast based on 18 Wall Street analysts shows a consensus price target of $83.4, with estimates ranging from $80 (bear case) to $86 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $83, with bear/bull scenarios of $52/$109.
What is NHI's fair value based on fundamentals?
Our quantitative valuation model calculates NHI's fair value at $83 (base case), with a bear case of $52 and bull case of $109. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
What is NHI's forward P/E ratio?
NHI trades at a forward P/E ratio of 19.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy NHI stock?
Wall Street analysts are optimistic on NHI, with a "Hold" consensus rating and $83.4 price target (17.8% upside). 6 of 18 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NHI price targets vary so much?
NHI analyst price targets range from $80 to $86, a 7% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $83.4 consensus represents the middle ground. Our model's $52-$109 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare